Carbazeran (citrate)
Carbazeran (citrate), a potent phosphodiesterase inhibitor, is aldehyde oxidase substrate. Carbazeran (citrate) can be used for the research of metabolic disease[1].
Product Specifications
CAS Number
153473-94-0
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/carbazeran-citrate.html
Solubility
10 mM in DMSO
Smiles
O=C(OC1CCN(C2=NN=CC3=C2C=C(OC)C(OC)=C3)CC1)NCC.O=C(CC(C(O)=O)(O)CC(O)=O)O
Molecular Formula
C24H32N4O11
Molecular Weight
552.53
References & Citations
[1]Uehara S, et al. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes. Drug Metab Dispos. 2020;48 (7) :580-586.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941884-100 1x 100 µL
Thymidylate Synthase (5-FU Resistance Marker) (TYMS/1884), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
